Clinical trials
Recruiting Phase 1 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Acerand Therapeutics (Hong Kong) Limited | 1 |
| AdventHealth | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Duboce Biopharmaceuticals, Inc. | 1 |
| Eli Lilly and Company | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Fox Chase Cancer Center | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Plexium, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 13 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Prostatic Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Carcinoma, Squamous Cell | 2 |
| Carcinoma, Transitional Cell | 2 |
| Neoplasm Metastasis | 2 |
| Adenocarcinoma of Lung | 1 |
| Basal Cell Carcinoma | 1 |
| Carcinoma, Ductal | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.